FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

10150411000001104: Potassium canrenoate 200mg/10ml solution for injection ampoules 10 ampoule (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
32236501000001111 Potassium canrenoate 200mg/10ml solution for injection ampoules 10 ampoule (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
32236601000001110 Potassium canrenoate 200mg/10ml solution for injection ampoules 10 ampoule en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Potassium canrenoate 200mg/10ml solution for injection ampoules 10 ampoule Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Potassium canrenoate 200mg/10ml solution for injection ampoules 10 ampoule Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Potassium canrenoate 200mg/10ml solution for injection ampoules 10 ampoule Is pack of Potassium canrenoate 200mg/10ml solution for injection ampoules false Inferred relationship Existential restriction modifier
Potassium canrenoate 200mg/10ml solution for injection ampoules 10 ampoule Has active ingredient Potassium canrenoate false Inferred relationship Existential restriction modifier
Potassium canrenoate 200mg/10ml solution for injection ampoules 10 ampoule VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Potassium canrenoate 200mg/10ml solution for injection ampoules 10 ampoule VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Potassium canrenoate 200mg/10ml solution for injection ampoules 10 ampoule Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Potassium canrenoate 200mg/10ml solution for injection ampoules 10 ampoule Has VMP Potassium canrenoate 200mg/10ml solution for injection ampoules true Inferred relationship Existential restriction modifier
Potassium canrenoate 200mg/10ml solution for injection ampoules 10 ampoule Has specific active ingredient Potassium canrenoate true Inferred relationship Existential restriction modifier
Potassium canrenoate 200mg/10ml solution for injection ampoules 10 ampoule Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Aldactone 200mg/10ml solution for injection ampoules (Hoffman-La Roche AG) 10 ampoule Is a True Potassium canrenoate 200mg/10ml solution for injection ampoules 10 ampoule Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start